234 related articles for article (PubMed ID: 868205)
1. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
2. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
3. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
Amlot PL; Unger A
Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
[TBL] [Abstract][Full Text] [Related]
4. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
5. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
6. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
Land JM; Litwin J; Bigel P; Oberling F; Mayer S
Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
[TBL] [Abstract][Full Text] [Related]
7. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
[TBL] [Abstract][Full Text] [Related]
8. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
9. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Nilsson P
J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
11. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte function in patients with Hodgkin's disease.
Rühl H; Vogt W; Rühl U
G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
[TBL] [Abstract][Full Text] [Related]
13. [Role of splenectomy in impairing lymphocyte elimination in patients with lymphogranulomatosis].
Kuz'mina EG; Bogatyreva TI; Baĭsogolov GD; Iarilin AA
Vopr Onkol; 1986; 32(8):65-8. PubMed ID: 3765511
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
15. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
Babacan E; Cavdar AO; Arcasoy A
Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
[TBL] [Abstract][Full Text] [Related]
16. [A micro-method for PHA-induced stimulation of human lymphocytes. I. Communication: Technical considerations (author's transl)].
Pees H; Pappas A
Z Immunitatsforsch Exp Klin Immunol; 1975 Oct; 150(4):309-17. PubMed ID: 129974
[TBL] [Abstract][Full Text] [Related]
17. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
Wagener DJ; Geestman E; Wessels HM
Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
[TBL] [Abstract][Full Text] [Related]
18. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Johansson B
Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
[TBL] [Abstract][Full Text] [Related]
20. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]